Skip to main content
Equibles
FTH logo

FTH · Faeth Therapeutics, Inc. · Proposed Sales

Track FTH — free

Use FTH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research FTH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$29.74 +1.67 (+5.95%) At close · Sep 30
Rebalance outlook locked
Going-concern doubt — cleared Aug 4, 2026

The latest filing no longer states the doubt (first flagged May 15, 2026).

View the 10-Q filed Aug 4, 2026
Market Cap
$723.53M
Shares
25.84M
Volume · Sep 30 356.52K Avg daily vol (3M) 338.77K

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-08-11 Cambrian BioPharma Inc 130,142
2026-04-29 Cambrian BioPharma Inc 155,142
2026-02-24 Celebi John 3,374
2026-02-18 Peyer James 950
2026-01-27 RINGO WILLIAM R 1,169
2025-12-09 Peyer James 841
2025-12-04 Cambrian BioPharma Inc 21,222
2025-12-04 Cambrian BioPharma Inc 5,844
Showing 1–8 of 8 filings
Key facts CIK 1829802 CUSIP 81728A207 13F (30d) 2 filings 2 filers Visit website Investor relations